Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in imaging of brain abnormalities in neuromuscular disease. | Ther Adv Neurol Disord | 2019 | 31105770 | PubTator, text mining | PubMed |
| PLEKHA4/kramer Attenuates Dishevelled Ubiquitination to Modulate Wnt and Planar Cell Polarity Signaling. | Cell Rep | 2019 | 31091453 | PubTator, text mining | PubMed |
| TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa. | Prostate | 2019 | 31090091 | PubTator, text mining | PubMed |
| Quantile regression analysis reveals widespread evidence for gene-environment or gene-gene interactions in myopia development. | Commun Biol | 2019 | 31069276 | PubTator, text mining | PubMed |
| Congenital muscular dystrophies in China. | Clin Genet | 2019 | 31066047 | PubTator, text mining | PubMed |
| Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. | Mol Cell Proteomics | 2019 | 31061140 | PubTator, text mining | PubMed |
| Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. | Toxicol Lett | 2019 | 31054353 | PubTator, text mining | PubMed |
| Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G. | Neurol Genet | 2019 | 31041397 | PubTator, text mining | PubMed |
| Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI. | Neuromuscul Disord | 2019 | 31040037 | PubTator, text mining | PubMed |
| NoMAS: A Computational Approach to Find Mutated Subnetworks Associated With Survival in Genome-Wide Cancer Studies. | Front Genet | 2019 | 31024613 | PubTator, text mining | PubMed |
| Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database. | Med Sci Monit | 2019 | 31020952 | PubTator, text mining | PubMed |
| The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis. | Int J Mol Sci | 2019 | 31013615 | PubTator, text mining | PubMed |
| Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion. | Muscle Nerve | 2019 | 30990900 | PubTator, text mining | PubMed |
| Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions. | Mol Neurobiol | 2019 | 30989628 | PubTator, text mining | PubMed |
| Identification of key genes involved in the metastasis of clear cell renal cell carcinoma. | Oncol Lett | 2019 | 30988807 | PubTator, text mining | PubMed |
| Analysis of α-Dystroglycan/LG Domain Binding Modes: Investigating Protein Motifs That Regulate the Affinity of Isolated LG Domains. | Front Mol Biosci | 2019 | 30984766 | PubTator, text mining | PubMed |
| Pericytes Favor Oligodendrocyte Fate Choice in Adult Neural Stem Cells. | Front Cell Neurosci | 2019 | 30971893 | PubTator, text mining | PubMed |
| A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy. | J Neurol | 2019 | 30963254 | PubTator, text mining | PubMed |
| Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report. | BMC Pediatr | 2019 | 30961548 | PubTator, text mining | PubMed |
| Embryonic stem cell- and transcriptomics-based in vitro analyses reveal that bisphenols A, F and S have similar and very complex potential developmental toxicities. | Ecotoxicol Environ Saf | 2019 | 30951980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=54